APOE isoform affects protein structure and function in normal brain
APOE isoform affects protein structure and function in normal brain
批准号:
10191057
负责人:
G WILLIAM REBECK
金额:
$38.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-15 至 2023-05-31
关键词:
ATP binding cassette transporter 1AffectAgeAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAnimalsAnti-Inflammatory AgentsAstrocytesBehaviorBindingBinding ProteinsBiochemicalBiochemistryBiologyBrainCell Culture TechniquesCholesterolChronicComplexComputer ModelsDataDiseaseEconomicsEnvironmentExerciseGenotypeGoalsHomeostasisHumanIbuprofenIn VitroIncidenceIndividualInflammationKnock-in MouseLDL-Receptor Related Protein 1LeadLearningLifeLipid BindingLipid BiochemistryLipidsLipoproteinsMass Spectrum AnalysisMeasuresMembraneMetabolismModelingModificationMorphologyMusNeuronsPathogenesisPathologicPatternPharmaceutical PreparationsPhenotypePlasmaPolysaccharidesPopulationPost-Translational Protein ProcessingPrevention approachPreventive treatmentProcessProductionProtein IsoformsProteinsResearchRiskRoleSiteSocietiesStructureSystemTestingTissuesTravelWaterWorkabeta accumulationbaseenvironmental enrichment for laboratory animalsexercise regimenexperimental studygenetic risk factorglycosylationin vivoinsightlipid metabolismmouse modelneurochemistryneuroinflammationneuropathologynovel markerpreventpreventive interventionprotein structure functiontraffickinguptake
中文摘要
APOE基因在阿尔茨海默病(AD)发病机制中的作用仍然是最关键的因素之一
AD研究中的问题。在过去的几年里,我们一直在追求一个有趣的假设,即APOE
在生命早期,基因会改变正常的大脑神经化学和结构,从而产生一个改变环境的环境
随着年龄的增长,阿尔茨海默病的风险。我们之前对APOE基因敲入小鼠的研究已经证明,即使在年轻的
对照小鼠大脑,APOE基因影响脑脂生物化学、神经元结构和空间学习。
在探索这些不同影响的原因时,我们现在正在测试一种假设,即早期的变化
APOE4患者的大脑是由于星形胶质细胞和
神经元。在初步研究中,我们发现从大脑中分离出来的载脂蛋白E存在于两个独立的
种群:要么是改性的和水溶性的,要么是未改性的和膜相关的。新的质量
光谱学方法使我们能够确定可溶性APOE是在几个位置糖基化的
几种类型的多糖;中枢神经系统中的大多数修饰的APOE在血浆中没有发现(特别是在
APOE在其脂结合结构域中的独特修饰)。体内研究表明,APOE4的脂化程度较低
脑脊液中脂蛋白与APOE2和APOE3的比较,以及APOE4小鼠改变了脑脂
动态平衡。最后,我们发现小鼠的APOE4相关表型可以被AD挽救
预防性治疗。在这项工作中,我们建议定义载脂蛋白E是如何影响脑脂平衡的
异构体,包括新发现的糖体。在目标1中,我们将定义APOE修改如何更改
载脂蛋白E在中枢神经系统中的代谢、运输和功能。对于这些研究,我们将确定和量化新的
APOE的跨组织翻译后修饰,并开发新的星形胶质细胞培养模型
人糖-载脂蛋白E亚型的表达和调控。在目标2中,我们将确定APOE4是否
在体外和体内导致脂质外流不良,导致小鼠和人类体内LXR靶标的激活增加
大脑。我们将使用计算机模拟来测试糖基APOE物种对APOE三级结构的影响
APOE与中枢神经系统脂蛋白结合的研究。在目标3中,我们将测试APOE4是否导致体内脂质摄取不足
体外,导致神经元载脂蛋白E代谢的变化。我们将使用神经胶质细胞和神经元培养来定义
APOE的修饰随着APOE穿过CNS舱室而改变。最后,在目标4中,我们将测试
预防小鼠和人类阿尔茨海默病的方法(抗炎药物和运动/环境
富集物)影响脑脂代谢和脑结构/功能。我们将测试我们的新记号笔是否
受到APOE4存在的影响,包括中枢神经系统特有的糖形式,对
降低AD风险。因此,这一建议为翻译后修饰提供了新的机械性见解
中枢的载脂蛋白E以及脑中复杂的载脂蛋白E亚型如何以多种方式调节脂代谢
这可能会增加患AD的风险。
英文摘要
The role of APOE genotype in the pathogenesis of Alzheimer's disease (AD) remains one of the most critical
questions in AD research. Over the past few years, we have pursued an interesting hypothesis that APOE
genotype alters normal brain neurochemistry and structure early in life, generating an environment that alters
the risk of AD with aging. Our previous studies of APOE knock-in mice have demonstrated that, even in young
control mouse brains, APOE genotype affects brain lipid biochemistry, neuronal structure, and spatial learning.
In exploring the cause of these various effects, we are now testing the hypothesis that early alterations of
brains in APOE4 individuals are due to differences in normal lipid metabolism in astrocytes and
neurons. In preliminary studies, we found that APOE isolated from the brain exists in two separate
populations: either modified and water soluble, or unmodified and membrane associated. New mass
spectrometry approaches allowed us to define that soluble APOE was glycosylated at several sites with
several types of glycans; most of the modified APOE in the CNS was not found in the plasma (particularly with
unique modification of APOE in its lipid binding domain). In vivo studies showed that APOE4 was less lipidated
in CSF lipoproteins compared to APOE2 and APOE3, and that APOE4 mice have altered brain lipid
homeostasis. Finally, we found that APOE4-associated phenotypes in mice were rescued by an AD
preventative treatment. In this work, we propose to define how brain lipid homeostasis is affected by APOE
isoforms, including the newly identified glycoforms. In Aim 1, we will define how APOE modifications alter
APOE metabolism, trafficking, and function in the CNS. For these studies, we will identify and quantify new
post-translational modifications of APOE across tissues, and develop new astrocyte culture models for
expression and modulation of human glyco-APOE isoforms. In Aim 2, we will determine whether APOE4
causes poor lipid efflux in vitro and in vivo, leading to increased activation of LXR targets in mouse and human
brains. We will use computer modeling to test the effects of glyco-APOE species on APOE tertiary structure
and on APOE binding to CNS lipoproteins. In Aim 3, we will test whether APOE4 causes poor lipid uptake in
vitro, leading to changes in neuronal APOE metabolism. We will use glial and neuronal cultures to define how
APOE modification changes as APOE travels through CNS compartments. Finally, in Aim 4, we will test
whether approaches that prevent AD in mice and humans (anti-inflammatory drugs and exercise/environmental
enrichment) affect brain lipid metabolism and brain structure/function. We will test whether our new markers
that are affected by the presence of APOE4, including the CNS-specific glycoforms, respond to conditions that
reduce AD risk. Thus, this proposal provides new mechanistic insight into the post-translational modification of
APOE in the CNS and how the complex set of APOE isoforms in the brain modulate lipid metabolism in ways
that could lead to increased risk of AD.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/ijms21176336
发表时间:
2020-09-01
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Lanfranco MF, Ng CA, Rebeck GW]
通讯作者:
Rebeck GW
DOI:
10.1186/s12974-021-02256-2
发表时间:
2021-09-18
期刊:
Journal of neuroinflammation
影响因子:
9.3
作者:
[Jones NS, Watson KQ, Rebeck GW]
通讯作者:
Rebeck GW
DOI:
10.2174/1567205013666160401115127
发表时间:
2016
期刊:
Current Alzheimer research
影响因子:
2.1
作者:
[Di Battista AM, Heinsinger NM, Rebeck GW]
通讯作者:
Rebeck GW
DOI:
10.1111/jnc.15665
发表时间:
2022-11
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[]
通讯作者:
DOI:
10.1002/glia.23974
发表时间:
2021-06
期刊:
Glia
影响因子:
6.2
作者:
[Lanfranco MF, Sepulveda J, Kopetsky G, Rebeck GW]
通讯作者:
Rebeck GW
共 7 条
Aging and Alzheimer's Research Training
-
批准号:10483115
-
项目类别:
-
资助金额:$51.59万
-
财政年份:2021
-
负责人:G WILLIAM REBECK
-
依托单位:
Synergistic effect of APOE genotype and obesity in CNS inflammation and risk of Alzheimer's disease
-
批准号:10458780
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2021
-
负责人:G WILLIAM REBECK
-
依托单位:
Synergistic effect of APOE genotype and obesity in CNS inflammation and risk of Alzheimer's disease
-
批准号:10300827
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2021
-
负责人:G WILLIAM REBECK
-
依托单位:
Aging and Alzheimer's Research Training
-
批准号:10671700
-
项目类别:
-
资助金额:$50.28万
-
财政年份:2021
-
负责人:G WILLIAM REBECK
-
依托单位:
Aging and Alzheimer's Research Training
-
批准号:10187377
-
项目类别:
-
资助金额:$21.81万
-
财政年份:2021
-
负责人:G WILLIAM REBECK
-
依托单位:
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment
-
批准号:10565894
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2020
-
负责人:G WILLIAM REBECK
-
依托单位:
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment
-
批准号:10393776
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2020
-
负责人:G WILLIAM REBECK
-
依托单位:
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment
-
批准号:10334558
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2020
-
负责人:G WILLIAM REBECK
-
依托单位:
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment
-
批准号:10162471
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2020
-
负责人:G WILLIAM REBECK
-
依托单位:
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment
-
批准号:10561227
-
项目类别:
-
资助金额:$6.82万
-
财政年份:2020
-
负责人:G WILLIAM REBECK
-
依托单位:
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment
-
批准号:10765106
-
项目类别:
-
资助金额:$2.84万
-
财政年份:2020
-
负责人:G WILLIAM REBECK
-
依托单位:
Molecular actions of VLDLR in dendritic spine formation
-
批准号:8516935
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2012
-
负责人:G WILLIAM REBECK
-
依托单位:
ApOE effects on neuron signaling and function via ApoER2
-
批准号:8135051
-
项目类别:
-
资助金额:$50.78万
-
财政年份:2010
-
负责人:G WILLIAM REBECK
-
依托单位:
ApOE effects on neuron signaling and function via ApoER2
-
批准号:8312020
-
项目类别:
-
资助金额:$5.77万
-
财政年份:2010
-
负责人:G WILLIAM REBECK
-
依托单位:
ApOE effects on neuron signaling and function via ApoER2
-
批准号:8306200
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2010
-
负责人:G WILLIAM REBECK
-
依托单位:
ApOE effects on neuron signaling and function via ApoER2
-
批准号:8519189
-
项目类别:
-
资助金额:$47.95万
-
财政年份:2010
-
负责人:G WILLIAM REBECK
-
依托单位:
ApOE effects on neuron signaling and function via ApoER2
-
批准号:8010296
-
项目类别:
-
资助金额:$54.53万
-
财政年份:2010
-
负责人:G WILLIAM REBECK
-
依托单位:
TRAFFICKING, SHREDDING, AND FUNCTIONS OF APOER2
-
批准号:7580223
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2009
-
负责人:G WILLIAM REBECK
-
依托单位:
Fyn modulation of APP processing
-
批准号:7382667
-
项目类别:
-
资助金额:$6.52万
-
财政年份:2008
-
负责人:G WILLIAM REBECK
-
依托单位:
Fyn modulation of APP processing
-
批准号:7575770
-
项目类别:
-
资助金额:$6.52万
-
财政年份:2008
-
负责人:G WILLIAM REBECK
-
依托单位:
海外基金